Advanced Bionics' cochlear implant approval:
This article was originally published in Clinica
Executive Summary
The US FDA has approved Advanced Bionics' latest Clarion cochlear implant. All adult recipients of the 1.2 version implant could hear speech at comfortable levels (50-55 dB) at six months and 74% had improved open-set sentence recognition without lip-reading in a 68-patient US multi-centre trial. The Clarion has been implanted in over 800 adults and children worldwide since the first model was launched in June 1991. Advanced Bionics is based in California and has European offices in France, Germany and the UK.
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.